The five Boston tech companies that raised the most funding in March brought in a combined $284.3 million — an increase over February’s biggest funding rounds. Among the companies that gained new capital were three local healthtech businesses creating solutions for healthy aging, neurodegenerative disease treatment and more efficient care delivery. Read on to learn about the innovative Boston tech companies that pulled in the most financing last month.
Largest Boston Tech Funding Rounds, March 2023
- Divert
- Cognito Therapeutics
- Assured Allies
- Zus Health
- Venti Technologies
#5. $28.8 million, March 28
Founded in 2018, Venti Technologies enables autonomous logistics vehicles for safer and more efficient operations at ports, airports, warehouses and factories. The company raised $28.8 million in Series A funding, bringing its total capital pulled in to date to $36.8 million. The funding will be used to grow Venti’s 80-person team and boost research and development for its autonomous solutions.
#4. $40 million, March 16
Zus Health is a shared health data platform that provides insights to inform care. Its solutions help providers save time and money, while also improving health outcomes and patient satisfaction. The healthtech company plans to enhance the platform’s capabilities using $40 million in capital secured in its most recent funding round.
#3. $42.5 million, March 7
Assured Allies uses data and technology, in partnership with long-term care insurance carriers, to support healthy aging so seniors can to live at home longer. Its products helps reduce claims with custom wellness interventions for high-risk policyholders and gives older adults resources to make proactive health choices. Assured Allies’ $42.5 million in Series B funding last month will allow the company to expand its network of partners and increase the availability of its products.
#2. $73 million, March 22
Cognito Therapeutics is a healthtech company working to better the lives of people who have neurodegenerative diseases. Cognito has created a headset that uses non-invasive sensory stimulation for treatment of diseases such as Alzheimer’s. The FDA granted Cognito’s headset Breakthrough Device Designation, and the company’s $73 million in Series B funding will finance a clinical trial to continue investigating the device’s effect on disease progression.
#1. $100 million, March 1
Since its founding in 2007, Concord-based Divert has been developing infrastructure and solutions to tackle food waste. Its strategy includes building facilities for turning food that would’ve been thrown out into renewable natural gas and sorting unsold goods to identify edible food for donation. The greentech company recently received $100 million in equity funding to further its mission.
.jpeg)
